Millennium Management’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.4K | Sell |
42,612
-198,636
| -82% | -$459K | ﹤0.01% | 3824 |
|
|
2025
Q1 | $1.88M | Sell |
241,248
-50,079
| -17% | -$391K | ﹤0.01% | 2633 |
|
|
2024
Q4 | $1.36M | Buy |
291,327
+88,823
| +44% | +$415K | ﹤0.01% | 2720 |
|
|
2024
Q3 | $1.09M | Buy |
202,504
+109,834
| +119% | +$592K | ﹤0.01% | 2875 |
|
|
2024
Q2 | $817K | Sell |
92,670
-66,522
| -42% | -$587K | ﹤0.01% | 2968 |
|
|
2024
Q1 | $1.87M | Buy |
159,192
+134,988
| +558% | +$1.59M | ﹤0.01% | 2641 |
|
|
2023
Q4 | $273K | Buy |
+24,204
| New | +$273K | ﹤0.01% | 3432 |
|
|
2023
Q3 | – | Sell |
-28,146
| Closed | -$256K | – | 4355 |
|
|
2023
Q2 | $256K | Buy |
28,146
+10,525
| +60% | +$95.6K | ﹤0.01% | 3607 |
|
|
2023
Q1 | $114K | Buy |
17,621
+989
| +6% | +$6.4K | ﹤0.01% | 4028 |
|
|
2022
Q4 | $105K | Sell |
16,632
-10,537
| -39% | -$66.5K | ﹤0.01% | 4290 |
|
|
2022
Q3 | $168K | Buy |
+27,169
| New | +$168K | ﹤0.01% | 4520 |
|
|
2022
Q1 | – | Sell |
-150,680
| Closed | -$1.54M | – | 5376 |
|
|
2021
Q4 | $1.54M | Buy |
150,680
+27,169
| +22% | +$277K | ﹤0.01% | 3153 |
|
|
2021
Q3 | $2.4M | Buy |
+123,511
| New | +$2.4M | ﹤0.01% | 2871 |
|
|
2021
Q2 | – | Sell |
-41,988
| Closed | -$499K | – | 5152 |
|
|
2021
Q1 | $499K | Buy |
+41,988
| New | +$499K | ﹤0.01% | 3663 |
|